Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2001 Sep;60(9):876–881.

Involvement of the peripheral nervous system in primary Sjögren's syndrome

P Barendregt 1, M J van den Bent 1, den V J M van Raaij-van 1, A H van den Meiracker 1, C Vecht 1, G L van der Heijde 1, H Markusse 1
PMCID: PMC1753829  PMID: 11502615

Abstract

BACKGROUND—Involvement of the peripheral nervous system in patients with primary Sjögren's syndrome (SS) has been reported, but its prevalence in neurologically asymptomatic patients is not well known.
OBJECTIVE—To assess clinical and neurophysiological features of the peripheral nervous system in patients with primary SS.
PATIENTS AND METHODS—39 (38 female) consecutive patients with primary SS, aged 20-81 years (mean 50), with a disease duration of 1-30 years (mean 8) were studied. The peripheral nervous system was evaluated by a questionnaire, physical examination, quantified sensory neurological examination, and neurophysiological measurements (nerve conduction studies). To assess autonomic cardiovascular function an orthostatic challenge test, a Valsalva manoeuvre, a forced respiration test, and pupillography were done.
RESULTS—Abnormalities as indicated in the questionnaire were found in 8/39 (21%) patients, while an abnormal neurological examination was found in 7/39 (18%) patients. Abnormalities in quantified sensory neurological examination were found in 22/38 (58%) patients. In 9/39 (23%) patients, neurophysiological signs compatible with a sensory polyneuropathy were found. No differences were found in the autonomic test results, disease duration, serological parameters, or erythrocyte sedimentation rate between the patients with primary SS with and those without evidence of peripheral nervous involvement.
CONCLUSION—Subclinical abnormalities of the peripheral nervous system may occur in patients with primary SS selected from a department of rheumatology, but clinically relevant involvement of the peripheral nervous system in this patient group is rare.



Full Text

The Full Text of this article is available as a PDF (161.5 KB).

graphic file with name ard-ppvm.f1.jpg

Open in a new tab

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander E. L. Neurologic disease in Sjögren's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. A clinical review and update of immunopathogenesis. Rheum Dis Clin North Am. 1993 Nov;19(4):869–908. [PubMed] [Google Scholar]
  2. Andonopoulos A. P., Christodoulou J., Ballas C., Bounas A., Alexopoulos D. Autonomic cardiovascular neuropathy in Sjögren's syndrome. A controlled study. J Rheumatol. 1998 Dec;25(12):2385–2388. [PubMed] [Google Scholar]
  3. Andonopoulos A. P., Lagos G., Drosos A. A., Moutsopoulos H. M. The spectrum of neurological involvement in Sjögren's syndrome. Br J Rheumatol. 1990 Feb;29(1):21–23. doi: 10.1093/rheumatology/29.1.21. [DOI] [PubMed] [Google Scholar]
  4. Barendregt P. J., Markusse H. M., Man In 't Veld A. J. Primary Sjögren's syndrome presenting as autonomic neuropathy. Case report. Neth J Med. 1998 Nov;53(5):196–200. doi: 10.1016/s0300-2977(98)00080-1. [DOI] [PubMed] [Google Scholar]
  5. Barendregt P. J., van Den Meiracker A. H., Markusse H. M., Tulen J. H., Boomsma F., van Der Heijde G. L., Veld A. J. Parasympathetic failure does not contribute to ocular dryness in primary Sjögren's syndrome. Ann Rheum Dis. 1999 Dec;58(12):746–750. doi: 10.1136/ard.58.12.746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bertelsmann F. W., Heimans J. J., Weber E. J., van der Veen E. A., Schouten J. A. Thermal discrimination thresholds in normal subjects and in patients with diabetic neuropathy. J Neurol Neurosurg Psychiatry. 1985 Jul;48(7):686–690. doi: 10.1136/jnnp.48.7.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Binder A., Snaith M. L., Isenberg D. Sjögren's syndrome: a study of its neurological complications. Br J Rheumatol. 1988 Aug;27(4):275–280. doi: 10.1093/rheumatology/27.4.275. [DOI] [PubMed] [Google Scholar]
  8. Denislic M., Meh D. Early asymmetric neuropathy in primary Sjögren's syndrome. J Neurol. 1997 Jun;244(6):383–387. doi: 10.1007/s004150050106. [DOI] [PubMed] [Google Scholar]
  9. Denislic M., Meh D. Neurophysiological assessment of peripheral neuropathy in primary Sjögren's syndrome. Clin Investig. 1994 Nov;72(11):822–829. doi: 10.1007/BF00190735. [DOI] [PubMed] [Google Scholar]
  10. Denislic M., Meh D., Popovic M., Kos-Golja M. Small nerve fibre dysfunction in a patient with Sjögren's syndrome. Neurophysiological and morphological confirmation. Scand J Rheumatol. 1995;24(4):257–259. doi: 10.3109/03009749509100886. [DOI] [PubMed] [Google Scholar]
  11. Elderson A., Gerritsen van der Hoop R., Haanstra W., Neijt J. P., Gispen W. H., Jennekens F. G. Vibration perception and thermoperception as quantitative measurements in the monitoring of cisplatin induced neurotoxicity. J Neurol Sci. 1989 Nov;93(2-3):167–174. doi: 10.1016/0022-510x(89)90187-1. [DOI] [PubMed] [Google Scholar]
  12. Elderson A., Gerritsen van der Hoop R., Haanstra W., Neijt J. P., Gispen W. H., Jennekens F. G. Vibration perception and thermoperception as quantitative measurements in the monitoring of cisplatin induced neurotoxicity. J Neurol Sci. 1989 Nov;93(2-3):167–174. doi: 10.1016/0022-510x(89)90187-1. [DOI] [PubMed] [Google Scholar]
  13. Gemignani F., Marbini A., Pavesi G., Di Vittorio S., Manganelli P., Cenacchi G., Mancia D. Peripheral neuropathy associated with primary Sjögren's syndrome. J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):983–986. doi: 10.1136/jnnp.57.8.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Goldberg J. M., Lindblom U. Standardised method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation. J Neurol Neurosurg Psychiatry. 1979 Sep;42(9):793–803. doi: 10.1136/jnnp.42.9.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Grant I. A., Hunder G. G., Homburger H. A., Dyck P. J. Peripheral neuropathy associated with sicca complex. Neurology. 1997 Apr;48(4):855–862. doi: 10.1212/wnl.48.4.855. [DOI] [PubMed] [Google Scholar]
  16. Hietaharju A., Yli-Kerttula U., Häkkinen V., Frey H. Nervous system manifestations in Sjögren's syndrome. Acta Neurol Scand. 1990 Feb;81(2):144–152. doi: 10.1111/j.1600-0404.1990.tb00951.x. [DOI] [PubMed] [Google Scholar]
  17. Hilkens P. H., Verweij J., Stoter G., Vecht C. J., van Putten W. L., van den Bent M. J. Peripheral neurotoxicity induced by docetaxel. Neurology. 1996 Jan;46(1):104–108. doi: 10.1212/wnl.46.1.104. [DOI] [PubMed] [Google Scholar]
  18. Lipton R. B., Galer B. S., Dutcher J. P., Portenoy R. K., Pahmer V., Meller F., Arezzo J. C., Wiernik P. H. Large and small fibre type sensory dysfunction in patients with cancer. J Neurol Neurosurg Psychiatry. 1991 Aug;54(8):706–709. doi: 10.1136/jnnp.54.8.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lluch I., Hernández A., Real J. T., Morillas C., Tenés S., Sánchez C., Ascaso J. F. Cardiovascular autonomic neuropathy in type 1 diabetic patients with and without peripheral neuropathy. Diabetes Res Clin Pract. 1998 Oct;42(1):35–40. doi: 10.1016/s0168-8227(98)00087-4. [DOI] [PubMed] [Google Scholar]
  20. Mandl T., Jacobsson L., Lilja B., Sundkvist G., Manthorpe R. Disturbances of autonomic nervous function in primary Sjögren's syndrome. Scand J Rheumatol. 1997;26(4):253–258. doi: 10.3109/03009749709105312. [DOI] [PubMed] [Google Scholar]
  21. Markusse H. M., van Putten W. I., Breedveld F. C., Oudkerk M. Digital subtraction sialography of the parotid glands in primary Sjögren's syndrome. J Rheumatol. 1993 Feb;20(2):279–283. [PubMed] [Google Scholar]
  22. Mauch E., Völk C., Kratzsch G., Krapf H., Kornhuber H. H., Laufen H., Hummel K. J. Neurological and neuropsychiatric dysfunction in primary Sjögren's syndrome. Acta Neurol Scand. 1994 Jan;89(1):31–35. [PubMed] [Google Scholar]
  23. Moore P. M., Richardson B. Neurology of the vasculitides and connective tissue diseases. J Neurol Neurosurg Psychiatry. 1998 Jul;65(1):10–22. doi: 10.1136/jnnp.65.1.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Moutsopoulos H. M., Sarmas J. H., Talal N. Is central nervous system involvement a systemic manifestation of primary Sjögren's syndrome? Rheum Dis Clin North Am. 1993 Nov;19(4):909–912. [PubMed] [Google Scholar]
  25. Pascual J., Cid C., Berciano J. High-dose i.v. immunoglobulin for peripheral neuropathy associated with Sjögren's syndrome. Neurology. 1998 Aug;51(2):650–651. doi: 10.1212/wnl.51.2.650-b. [DOI] [PubMed] [Google Scholar]
  26. Peyronnard J. M., Charron L., Beaudet F., Couture F. Vasculitic neuropathy in rheumatoid disease and Sjögren syndrome. Neurology. 1982 Aug;32(8):839–845. doi: 10.1212/wnl.32.8.839. [DOI] [PubMed] [Google Scholar]
  27. Provost T. T., Vasily D., Alexander E. Sjögren's syndrome. Cutaneous, immunologic, and nervous system manifestations. Neurol Clin. 1987 Aug;5(3):405–426. [PubMed] [Google Scholar]
  28. Ratzmann K. P., Raschke M., Gander I., Schimke E. Prevalence of peripheral and autonomic neuropathy in newly diagnosed type II (noninsulin-dependent) diabetes. J Diabet Complications. 1991 Jan-Mar;5(1):1–5. doi: 10.1016/0891-6632(91)90002-7. [DOI] [PubMed] [Google Scholar]
  29. Vitali C., Bombardieri S., Moutsopoulos H. M., Balestrieri G., Bencivelli W., Bernstein R. M., Bjerrum K. B., Braga S., Coll J., de Vita S. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 1993 Mar;36(3):340–347. doi: 10.1002/art.1780360309. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES